Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF) Sees Significant Drop in Short Interest

Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPFGet Rating) saw a significant decline in short interest in July. As of July 15th, there was short interest totalling 500 shares, a decline of 87.2% from the June 30th total of 3,900 shares. Based on an average daily trading volume, of 1,700 shares, the short-interest ratio is currently 0.3 days.

Algernon Pharmaceuticals Trading Up 5.0 %

OTCMKTS AGNPF opened at $2.47 on Thursday. Algernon Pharmaceuticals has a 1-year low of $2.30 and a 1-year high of $10.85. The company has a 50 day moving average of $3.38 and a 200-day moving average of $4.36.

Algernon Pharmaceuticals Company Profile

(Get Rating)

Algernon Pharmaceuticals Inc operates as a clinical stage pharmaceutical development company. It focuses on the areas of non-alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, and acute lung injury associated with COVID-19 in Canada and Australia.

Featured Stories

Receive News & Ratings for Algernon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Algernon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.